Corona Remedies is launching its Rs 655 crore IPO next week. The Gujarat-based pharmaceutical firm is offering 100% of its shares. The grey market premium indicates a potential 29% upside. Investors can subscribe from December 8 to 10. The company has strong financial growth and high return ratios. Shares will list on NSE and BSE.

See Full Page